GC Biopharma Corp. (KRX:006280)

GC Biopharma Revenue

GC Biopharma had revenue of 421.18B KRW in the quarter ending June 30, 2026, a decrease of -15.81%. This brings the company's total for the last twelve months to 1.96T, up 9.73% year-over-year. In the year 2025, GC Biopharma had annual revenue of 1.99T with 18.54% growth. That makes GC Biopharma the 6,004th largest company in the world by revenue and 262nd in South Korea.

• Revenue (ttm): 1.96T
• Revenue Growth: +9.73%
• P/S Ratio: 0.75
• Revenue / Employee: 930.34M
• Employees: 2,111
• Market Cap: 1.49T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Manufacturing and Sales of Pharmaceuticals, Etc. 1.98T 91.0%
• Diagnosis and Analysis of Samples, Etc. 181.90B 8.3%
• Other 14.15B 0.6%

By Geography

Chart

• South Korea 1.55T 71.2%
• Overseas 626.44B 28.8%

Fiscal year ended Dec 31, 2025 See the full GC Biopharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.99T	311.39B	18.54%
Dec 31, 2024	1.68T	53.25B	3.27%
Dec 31, 2023	1.63T	-84.67B	-4.95%
Dec 31, 2022	1.71T	173.49B	11.28%
Dec 31, 2021	1.54T	33.71B	2.24%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error